Search Results - Xingfeng Bao
- Showing 1 - 3 results of 3
-
1
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers by Xingfeng Bao, Andrea Varga, David S Hong, Aparna Parikh, Geoffrey I Shapiro, Özlem Ataman, Larisa Reyderman, Terri A Binder, Min Ren, Mingjie Liu, Satish Dayal, Amy Y Siu, Pallavi Sachdev, Lucy Xu, Vijay Bhagawati-Prasad, Ilian Tchakov, Chean Eng Ooi
Published 2020-06-01
Article -
2
EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity by Diana I. Albu, Zichun Wang, Kuan-Chun Huang, Jiayi Wu, Natalie Twine, Sarah Leacu, Christy Ingersoll, Lana Parent, Winnie Lee, Diana Liu, Renee Wright-Michaud, Namita Kumar, Galina Kuznetsov, Qian Chen, Wanjun Zheng, Kenichi Nomoto, Mary Woodall-Jappe, Xingfeng Bao
Published 2017-08-01
Article -
3
Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells. by Yuki Ito, Jose Luis Vela, Fumiko Matsumura, Hitomi Hoshino, Aaron Tyznik, Heeseob Lee, Enrico Girardi, Dirk M Zajonc, Robert Liddington, Motohiro Kobayashi, Xingfeng Bao, Jeanna Bugaytsova, Thomas Borén, Rongsheng Jin, Yinong Zong, Peter H Seeberger, Jun Nakayama, Mitchell Kronenberg, Minoru Fukuda
Published 2013-01-01
Article